# Use of Saliva for Alzheimer's Disease Diagnosis

> **NCT02864303** · NA · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 88 (actual)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment

## Interventions

- **OTHER:** Saliva samples

## Key facts

- **NCT ID:** NCT02864303
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06-21
- **Primary completion:** 2018-10-11
- **Final completion:** 2018-10-11
- **Target enrollment:** 88 (ACTUAL)
- **Why stopped:** end of the inclusion period
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864303, "Use of Saliva for Alzheimer's Disease Diagnosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02864303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
